Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Nephrology
Clinical Trials: Nephritis
A listing of clinical trials currently looking for volunteers to enroll in Nephritis studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Birmingham : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
California
Los Angeles : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Los Angeles : Mohamed A. El-Shahawy
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
Northridge : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
San Leandro : GSK Investigational Site
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Colorado
Centennial : IMMUNOe International Research Centers
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
District of Columbia
Washington : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Florida
Orlando : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Weston : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Georgia
Atlanta : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Illinois
Chicago :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Chicago : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Evanston : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Minnesota
Rochester : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Missouri
St. Louis : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
New Jersey
Newark : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
New York
Bronx : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lake Success :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Lake Success : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
New York : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
New York : Columbia University Medical Center, Division of Nephrology, Glomerular Center
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
View More »
Springfield Gardens : Clinical Research Development Associates, LLC
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
North Carolina
Chapel Hill : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Raleigh : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Ohio
Columbus :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Columbus : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Pennsylvania
Duncansville :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
South Carolina
Orangeburg : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Tennessee
Chattanooga :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Chattanooga : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Memphis : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Memphis : Ramesh Gupta
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
Texas
Austin : GSK Investigational Site
Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Carrollton : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Carrollton :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Dallas : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
El Paso : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Argentina
Ciudad Autónoma de Buenos Aires : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Cordoba : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
San Miguel de Tucuman : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Santa Fe : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Australia
Melbourne : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Belgium
Brussels :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Gent : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Leuven :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Leuven : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Liege : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
View More »
Roeselare :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
China
Beijing :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Fujian :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Hubei :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Hunan :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Jiangsu :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
View More »
Jilin :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Liaoning :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shandong :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shanghai :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Shanxi :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Sichuan :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Zhejiang :
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Colombia
Barranquilla : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Medelin : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
France
Creteil Cedex : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lille : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lyon : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Paris : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Paris Cedex 13 : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Germany
Aachen : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Muenchen : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Ulm : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Hong Kong
Hong Kong : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Hong Kong : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Italy
Brescia : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Padova : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Pisa : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Japan
Chubu :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Hokkaido :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kansai :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kantou :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Kyusyu :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
View More »
Shagoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Shikoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Touhoku :
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Korea, Republic of
Busan :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Busan : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Daegu :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Daegu : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Daejeon :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
View More »
Gwangju :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Gwangju : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Gyeonggi-do : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Incheon :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Jeonju :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Seoul :
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Seoul : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Malaysia
Kuala Lumpur : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
Kuantan,Pahang : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Selangor : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Selangor Darul Ehsan : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Mexico
Guadalajara :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Guadalajara : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Guadalajara, Jalisco :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Mexico :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Mexico : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
View More »
Mexico : Research Site
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis
México :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Monterrey : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Querétaro : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Netherlands
Maastricht :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Rotterdam :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Peru
Arequipa : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lima : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Philippines
Quezon City : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Poland
Gdansk : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Gdansk :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Warszawa : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Warszawa :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Wroclaw :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Portugal
Almada : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Coimbra : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Lisboa : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Porto : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
South Africa
Bloemfontein : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Cape Town : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Pretoria : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Spain
Barcelona : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Madrid : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Malaga : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Sevilla : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Zaragoza : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
Thailand
Bangkok :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Bangkok : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Chiang Mai : Updated
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Chiang Mai :
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
Patumwan : Research Site
ATLAS - Anti-Tweak in Lupus Nephritis Patients
